
Kimia Biosciences Ltd is Rated Sell
2026-05-13 10:11:11Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Kimia Biosciences Ltd is Rated Sell
2026-04-21 10:10:52Kimia Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Kimia Biosciences Ltd Upgraded to Sell on Technical Improvement Despite Lingering Fundamental Concerns
2026-04-10 08:03:46Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 9 April 2026, driven primarily by improvements in its technical outlook despite ongoing fundamental challenges. This shift reflects a nuanced reassessment across quality, valuation, financial trends, and technical indicators, signalling a cautious but more optimistic stance on the micro-cap pharmaceutical company.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-04-06 10:10:39Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreKimia Biosciences Falls 13.45%: Downgrade and 52-Week Low Mark a Challenging Week
2026-03-28 16:11:31Key Events This Week Mar 23: Downgrade to Strong Sell announced; stock closes at Rs.28.00 (-4.44%) Mar 24: Stock rebounds modestly to Rs.28.67 (+2.39%) amid broader market gains Mar 25: Slight decline to Rs.28.46 (-0.73%) despite Sensex rally Mar 27: Stock plunges to 52-week low of Rs.24, closing at Rs.25.36 (-10.89%) Week OpenRs.29.30 <div class=...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSEPublication of Results for quarter and year ended March 31 2026
Outcome Of The Board Meeting Held On 29 May 2026
29-May-2026 | Source : BSEApproval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015
20-May-2026 | Source : BSEKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available